CODING Q&A
Ring in the Old, the New — and the Reduced
FOCUS ON...
All-in-one Pattern Scanning Laser/Slit Lamp Does It All With Ease
By Karen Appold, contributing writer
GUEST EDITORIAL
What Do I Think About 25% Vitrectomy Surgery Cuts — Bucket!
Innovation in Retina
Anthony P. (Tony) Adamis, MD
Intravitreal Aflibercept for Diabetic Macular Edema
We review the data on which approval of the newest anti-VEGF drug for DME was based.
Inventory Systems Keep Track of Injectables
Physicians can keep tabs, identify usage trends, assist with billing accuracy, and more.
IRIS Springs Into Action
The AAO’s registry, in combination with EHR, could be a valuable resource for retinal physicians.
JOURNAL CLUB
RECENT NOTEWORTHY STUDIES TO STIMULATE DISCUSSION AND DEBATE
Steroids in Diabetic Macular Edema
In sustained-release formats, these drugs have shown impressive evidence.
SUBSPECIALTY NEWS
By Jerry Helzner, contributing editor
Treatment of DME Beyond Anti-VEGF
The results with anti-VEGF drugs are impressive, but new target molecules could revolutionize DME care.
UPFRONT
Don’t Swing at Every Pitch
Vitrectomy for Diabetic Macular Edema
What do we know, and when is vitrectomy indicated?
Advances in Endoillumination for Microincision Vitreoretinal Surgery
By Colin A. McCannel, MD, Jules
Emerging Platforms for Better and Safer Vitreoretinal Surgery
By Peter W. Stalmans, MD, PhD, University
The Next Step in the Evolution of Vitrectomy Surgery Technology
By Asheesh Tewari, MD, Kresge
Vitreous Surgery Technology: Choice and Consistency During Surgery Are Key
By GAURAV K. SHAH, MD